Vanguard Group
ALXA

Vanguard Group’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Vanguard Group’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-683,411
Closed -$331K – 4160
2016
Q1 		$331K Hold
683,411
– – ﹤0.01% 3868
2015
Q4 		$479K Buy
683,411
+10,800
+2% +$11.1K ﹤0.01% 3845
2015
Q3 		$854K Hold
672,611
– – ﹤0.01% 3685
2015
Q2 		$733K Buy
672,611
+3,616
+0.5% +$5.43K ﹤0.01% 3751
2015
Q1 		$1.39M Buy
668,995
+34,000
+5% +$69.8K ﹤0.01% 3539
2014
Q4 		$946K Buy
634,995
+9,000
+1% +$16.1K ﹤0.01% 3544
2014
Q3 		$1.46M Buy
625,995
+219,171
+54% +$837K ﹤0.01% 3386
2014
Q2 		$1.86M Buy
406,824
+5,992
+1% +$25.9K ﹤0.01% 3285
2014
Q1 		$1.78M Buy
400,832
+31,100
+8% +$159K ﹤0.01% 3276
2013
Q4 		$1.75M Sell
369,732
-49,816
-12% -$244K ﹤0.01% 3239
2013
Q3 		$2.15M Buy
419,548
+66,050
+19% +$311K ﹤0.01% 3102
2013
Q2 		$1.53M Buy
+353,498
New +$1.6M ﹤0.01% 3161

Vanguard Group's ALXA Position: Q2 2016 in Review

Vanguard Group sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 683,411 shares — an estimated $331K sold.

Vanguard Group first reported a position in ALXA in Q2 2013 and held it in 12 quarters. The position peaked at $2.15M in Q3 2013. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

  • Vanguard Group reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Vanguard Group sold 683,411 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $331K.
  • Vanguard Group first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Vanguard Group's Alexza Pharmaceuticals Inc position peaked at $2.15M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Vanguard Group's 13F filing for Q2 2016, filed 10 Aug 2016.